Skip to product information
1 of 1

NSJ Bioreagents

SKU:V9328-100UG

Recombinant Keratin 20 Antibody / CK20 / Cytokeratin 20, 100 ug

Recombinant Keratin 20 Antibody / CK20 / Cytokeratin 20, 100 ug

Regular price $559.00 USD
Regular price Sale price $559.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

This MAb recognizes an intermediate filament protein of 46kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.

Specifications

Catalog No V9328-100UG
Family Primary antibody
Qty 100 ug
Formulation 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Format Purified
Clone KRT20/4879R
Host Animal Rabbit
Clonality Recombinant Rabbit Monoclonal
Isotype Rabbit IgG, kappa
Species Reactivity Human
Application IHC-P, WB
Application Details Immunohistochemistry (FFPE): 2-4ug/ml,Western blot: 2-4ug/ml
Application Note Optimal dilution of the recombinant Keratin 20 antibody should be determined by the researcher.
Localization Cytoplasmic
Immunogen A portion of amino acids 196-323 was used as the immunogen for the recombinant Keratin 20 antibody.
Purity Protein A/G affinity
Storage Aliquot the recombinant Keratin 20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This recombinant Keratin 20 antibody is available for research use only.
Uniprot # P35900
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/recombinant-keratin-20-antibody-ck20-cytokeratin-20-krt204879r-v9328
Title Recombinant Keratin 20 Antibody / CK20 / Cytokeratin 20
Description This MAb recognizes an intermediate filament protein of 46kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.
View full details